[A clinicoeconomic model of basic therapy for bronchial asthma].
The paper is dedicated to analysis of the most wide-spread variants of bronchial asthma (BA) basic therapy. The analysis was based on the results of a large (1362 patients from 34 Russian cities) pharmacoepidemiological study. Different models of pharmacotherapy were assessed on the basis of clinical data (the frequency of symptoms), the risk of BA exacerbation, the volume of public health resources used, and the cost of treatment. The results of the study showed that the use of set combinations of inhaled glucocorticosteroids and long-acting , beta2-adrenostimulators was most effective and rational from economic perspective under real clinical conditions.